SEC Form 4 · accession 0001127602-17-017792
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Francis Cogan
Director
Period of report
May 9, 2017
Accepted (ET)
May 11, 2017 · 6:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 9, 2017 | M | 1,787 | — | A | 47,562 | D | |
| Common Stock | May 9, 2017 | M | 15,000 | $20.705 | A | 62,562 | D | |
| Common Stock | May 9, 2017 | S | 9,943 | $67.25 | D | 52,619 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | May 9, 2017 | M | 1,787 | D | — | — | Common Stock | 1,787 | 0 | D |
| Non-qualified Stock Option (Right to Buy)F4 | $20.705 | May 9, 2017 | M | 15,000 | D | — | May 9, 2017 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- F2100% of the restricted stock units vested on May 9, 2017.
- F3The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F4Options are 100% vested on the date of grant.